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Abstract  
There are numerous existing techniques for forensic toxicological testing, but each one 
has limitations. Although there have been significant improvements in these techniques over the 
past 10 years, it still remains very difficult to successfully identify a wide range of drugs from 
one sample using a single method [12]. This difficulty arises from the major differences in 
molecular structure, volatility and stability in solution between these drugs. The overall goal of 
this study is to develop a method using gas chromatography (GC) coupled with triple quadrupole 
mass spectrometry (GC/MS/MS) to separate and accurately identify 10 different drugs of abuse 
from a single sample. The analytes of interest in this study are characterized as central nervous 
stimulants (amphetamine, methamphetamine and benzoylecgonine), central nervous system 
depressants (secobarbital, nortriptyline, and oxazepam), dissociative anesthetics (phencyclidine), 
narcotic analgesics (methadone and morphine), and tetrahydrocannabinol, the active ingredient 
in cannabis. The focus of this work is to discuss the chemical interactions occurring between the 
drugs during separation. Future work will include using the QuEChERS extraction technique to 
remove the drugs from biological matrices.  
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Chapter 1 – Introduction to QuEChERS and Silylation Reactions via Gas 
Chromatography 
1.1 – What is QuEChERS? 
QuEChERS (Quick, Easy, Cheap, Effective, Rugged, and Safe) is a liquid-liquid extraction 
technique combined with a dispersive solid phase extraction clean-up step. It was originally 
developed by Anastassiades while conducting postdoctoral research with Lehotay, and was 
designed for the extraction of drugs from animal tissues. QuEChERS proved to be very adept for 
polar, basic compounds and was then implemented to extract pesticides from plant matter. The 
first detailed publication using the QuEChERS method was completed by Anastassiades, 
Lehotay, Schenck, and Stajnbaher in 2003 for pesticide residues. In the years since, the 
QuEChERS method had gained recognition and was redeveloped into the European EN method, 
and the Association of Official Agricultural Chemists (AOAC) method [1].  
 This technique was given the name “Quick, Easy, Cheap, Effective, Rugged, and Safe” 
because it encompasses each of these characteristics. The QuEChERS method has only one 
partitioning step in a single vessel and relies on centrifugation and shaking (opposed to filtration 
and Ultra-Turrax) making this method Quicker than classical techniques. Being an overall 
simpler method compared to a method requiring evaporation or reconstitution techniques means 
QuEChERS is Easier than classical methods. Smaller sample amounts and a limited amount of 
solvents, allow this method to be Cheaper than classical methods.  The QuEChERS method is 
Rugged and Effective because it has a larger extraction range and results in less error than other 
methods. The last characteristic, Safe, is representative of the QuEChERS technique because all 
of the solvents and salts used are much safer than traditional methods. All solvents used are non-
halogenated, making them less dangerous to be exposed to [2]. 
10 
 
 As previously mentioned, the QuEChERS method involves combing a liquid-liquid 
extraction technique with a dispersive solid phase clean up technique. The method employed in 
this work follows the original method developed by Anastassiades. The initial liquid extraction 
used Acetonitrile (ACN) as the solvent of choice because it had the broadest extraction range 
with the least interferences, compared to Ethyl Acetate and Acetone. The salts used were 
Magnesium Sulfate (MgSO4), which improved partitioning and polar analyte recovery, and 
Sodium Chloride (NaCl), which decreased polar interferences. The dispersive solid phase 
extraction included salts such as Primary Secondary Amine (PSA) and MgSO4. PSA removes the 
most unwanted compounds from the solution like sugars, fatty acids, organic acids, lipids, and 
certain pigments compared to Graphitized Carbon Black, which removes pigments and polar 
interferences, and C18, which removes non-polar interferences [2]. This purpose of this study is 
to test the viability of this QuEChERS technique for use in forensic analysis of drugs of abuse.  
1.2 – Drugs of Abuse  
The analytes of interest in this study are common drugs of abuse, including several different 
categories that have varying effects on the human body. Drugs of abuse can be defined as drugs 
that are commonly used inappropriately or illegally. According to the International Drug 
Evaluation and Classification Program, drugs may be categorized or classified according to 
certain shared symptomatologies or effects [3]. The 10 drugs of abuse used in this analysis are 
amphetamine (AMP), methamphetamine (METH), benzoylecgonine (BZE), phencyclidine 
(PCP), methadone (MTD), morphine (MOR), secobarbital (SECO), nortriptyline (NOR), 
oxazepam (OXA), and delta-9 tetrahydrocannabinol (THC).   
AMP, METH, and BZE (a cocaine metabolite) all fall under the central nervous system 
stimulant category. These drugs “stimulate” the body by accelerating heart rate and elevating 
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blood pressure. PCP is an example of the dissociative anesthetics category, which includes drugs 
that alter the brain’s perception of pain. MTD and MOR are narcotic analgesics, meaning they 
relieve pain and create euphoric mood changes. SECO (a barbiturate derivative), NOR (an 
antidepressant), and OXA (a benzodiazepine) are all considered central nervous system 
depressants. The primary effect of depressants is slowed brain and body function. Lastly, THC is 
the active ingredient in cannabis (marijuana), a drug that induces a state of relaxation [3].The 
following are the structures for each drug of interest:  
Figure 1. Structure of Amphetamine (AMP)     Figure 2. Structure of Methamphetamine (METH) 
 
 
 
 
Figure 3. Structure of Phencyclidine (PCP)       Figure 4. Structure of Methadone (MTD) 
 
 
 
 
 
 
Figure 5. Structure of Benzoylecgonine (BZE)     Figure 6. Structure of Secobarbital (SECO) 
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Figure 7. Structure of Nortriptyline (NOR)         Figure 8. Structure of Oxazepam (OXA) 
  
 
 
 
 
 
 
Figure 9. Structure of Morphine (MOR)  Figure 10. Structure of d-9 tetrahydrocannabinol (THC) 
 
                           
 
 
 
1.3 – Gas Chromatography Mass Spectrometry (GC/MS) 
Gas chromatography (GC) combined with mass spectrometry (MS) is a very common and 
effective pairing for chemical analysis in separation science. The methodology in this study 
compares the qualitative abilities of GC/MS to GC/MS/MS using a Shimadzu GCMS-TQ8030. 
GC separates the components of a vaporized sample by using an inert gas to pass the analytes 
through a capillary column containing a stationary liquid phase. This study used Helium as the 
carrier gas and a RTX-5 capillary column (15m, 0.25mm, 0.25μm), which contains fused silica 
(dimethyl polysiloxane) as the stationary phase. Other gas phases that can be used in GC analysis 
include Hydrogen and Nitrogen. The sample, which is prepared in a non-aqueous solvent, is 
vaporized upon injection onto the chromatographic column [4]. The analytes will partition 
between the gaseous and liquid phases at varying ratios (defined as the retention factor), 
allowing each component to reach the MS detector at different times (called retention time).  
13 
 
 
The capillary columns used in GC can vary in size and type depending on the desired 
conditions. As mentioned above, the stationary phase in the RTX-5 column used in this 
experiment is 5% diphenyl – 95% dimethyl polysiloxane. Diameter (typically between 0.1mm 
and 0.25mm) directly effects the efficiency of the column by shifting retention times. A smaller 
diameter creates better separation between two peaks because they are further apart and therefore 
more easily distinguishable. The length of the column (typically between 15 and 60 meters) will 
have the opposite effect. The longer a column is, the greater the resolution is because retention 
time will be longer. Increasing the thickness of the stationary phase inside a column also 
improves resolution because it increases the distance between the peaks (retention time). 
Temperature is also an extremely influential partitioning factor in gas chromatography. A very 
high temperature will allow the analytes to pass through the column quickly, forcing the 
retention times to be closer and the chromatogram to have lower resolution. If peaks on a 
chromatogram are too close, choosing a lower temperature can help partition the peaks better. 
Using a programmed ramp method instead of analyzing with an isothermal method can also help 
improve resolution  
Figure 11. Schematic Diagram of a GC/MS. 
 
 
 
 
 
 
                                      
                                  
GC Oven  
Mass Spectrometer   
Detector  
Computer  
Injector  
GC Column 
Transfer Line 
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The data analysis software used in this study is called LabSolutions for GCMS solutions, 
version 4.20. This software properly analyzed the chromatographic data obtained. There are 
several values and figures this software automatically calculates to analyze data. The following 
are some of these important factors [6]: 
1. Retention factor represents sample-column interactions.  
                                                 𝑘 =
𝑡𝑟−𝑡0
𝑡0
 
tr = time where first peak is observed  
t0 = time where nothing is retained  
The ideal retention factor is between 1 and 5.  
2. Selectivity factor describes the relative retention value for two peaks. 
                                                   𝛼 =
𝑘1
𝑘2
  
k1 = retention factor 1 
k2 = retention factor 2  
 𝛼 should always be greater than 1.  
3. Resolution of a chromatogram measures how well two peaks are separated. 
                                             𝑅𝑠 =
2𝑑
(𝑤𝑏)𝐴+(𝑤𝑏)𝐵
  
d = distance between each peak (in time)  
(wb)A/(wb)B = peak widths 
If the resolution is 1.5 or greater, the peaks will not co-elude. If the resolution is less than 
1.5 the peaks will co-elude and they will not be distinguishable.  
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All of these factors and values need to be analyzed in order to make practical conclusions 
about the data. This analysis is an important step in the experimental process because it helps 
predict what the next steps in the experiment should be. 
As stated above, one of the analytical techniques employed in this study was GC/MS. In 
short, once the sample has passed through the GC column, it enters the ion source of the MS. 
Here, the sample is bombarded with electrons and ionized, resulting in smaller fragments. The 
ions are passed into the mass analyzer that contains a single quadrupole equipped with both 
positive and negative charges. The fragmented sample will interact with these charges at varying 
degrees before it finally reaches the detector and the mass spectrum is produced [5].  
The second technique employed in this study was the GC/MS/MS. The Shimadzu instrument 
is capable of analyzing samples using either single quadruple MS or triple quadrupole MS. This 
particular instrument combines GC with triple quadrupole tandem mass spectrometry, or 
MS/MS. MS/MS differs from single quadrupole MS in one significant way: it has three 
quadrupoles instead of one, which allows the mass spectrum of preselected and fragmented ions 
to be obtained, as well as detecting analytes at trace levels [5]. The first step in the MS/MS 
method is the same as single quadrupole MS: after the sample passes through the GC column, it 
enters the ion source where it undergoes electron ionization. The resulting fragments contain 
what is called the precursor, or parent, ion. The fragments are input into the first mass analyzer 
(first quadrupole, MS1) and the precursor ion is selected. The fragments are next sent into the 
second quadrupole (MS2). The MS2 is known as a collision cell, where the parent ion is further 
broken down into daughter ions, or product ions, by collisions with argon gas. The daughter ions 
are input into the second mass analyzer (third quadrupole, MS3) where the LabSolutions software 
16 
 
can be programed to discard any fragmentation patterns that are not desired. Lastly, the ions are 
identified by the ion detector [5].  
Figure 12. Schematic of Triple Quadrupole MS. 
[13] 
1.4 – Derivatization 
Derivatization is a technique used to chemically modify a compound to produce a new 
compound that is more suitable for specific types of analysis [7]. There are three main types of 
derivatization: silylation, alkylation and acylation. This study discusses the effect of the 
silylation reaction on the drugs of interest using N,O-Bis(trimethylsilyl)trifluoroacetamide + 
trimethylchlorosilane (BSTFA+1% TMCS). This silylating reagent can make samples more 
volatile for GC analysis by replacing the active hydrogens (on functional groups such as –OH, –
NH and –SH) with a trimethylsilyl group (TMS) [8]. This reaction occurs as an SN2 nucleophilic 
attack on the active hydrogens, alcohols first, then phenols, carboxyls, amine and finally amides.  
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Figure 13. BSTFA+1% TMCS Derivatization Mechanism 
[9] 
The advantage of using BSTFA+TMCS is that silylation can be used on a wide variety of 
compounds and reacts more completely than other silylation reagents. Since the 10 drugs of 
interest in this study vary greatly in size, shape, volatility etc., silylating each compound ensures 
the ability to perform sample analysis with GC. A disadvantage of the silylation reagent is its 
moisture sensitivity. The reagent is readily hydrolyzed and requires careful storage and handling 
to prevent degradation [8]. 
Several studies were conducted to investigate the potential interactions between the analytes 
of interest in this work. In chapter 2, the experiment discussed is the preliminary study that was 
the motivation for developing a method for the detection of 10 different drugs of abuse. The 
experiment attempted to extract and identify the analytes of interest from synthetic urine using 
QuEChERS. Chapter 3 discusses the identification of the drug standards both individually and in 
a mixture. Next, Chapter 4 considers the stability of the drug standards in methanol over time. 
The experiment done in Chapter 5 is very important for the overall goal of the study as it 
discusses which analytes cause the interferences with sensitivity the prevent proper identification 
in a mixture. Chapter 6 focuses on a specific result from the work in Chapter 5, the interaction 
between AMP and MTD. Chapter 7 combines the efforts from the previous chapters to develop a 
Multiple Reaction Monitoring method that can detect the analytes down to trace levels. Lastly, 
Chapter 8 discusses the optimization of the derivatization technique for BZE and THC.  
18 
 
MS Parameters
EI Source: 230˚C
Transfer Line: 280˚C
Oven Parameters 
60˚C (hold for 1 min)
20˚C/min to 300˚C (hold 3 min)
Chapter 2 – QuEChERS  
 Working with QuEChERS was the inspiration for this study. The experiment was 
performed as a collaboration with Dr. Michelle Schmidt. The sample preparation involved 
combining 500mg MgSO4, 500mg NaCl and 2mL ACN to 2mL synthetic urine in a centrifuge 
tube. The tube was vortexed for 1 minute and centrifuged for 3 minutes. The organic layer was 
transferred to a QuEChERS tube containing 50mg PSA and 150mg MgSO4. The QuEChERS 
tube was vortexed for 1 minute and centrifuged for 3 minutes.  This extract was analyzed using 
an Agilent 6890 GC/MS under the following conditions:  
Column: DB5-MS UI 30mx0.25mmx0.25µm 
 
Table 1. Instrumental GC Parameters    Table 2. Instrumental MS and Oven Parameters 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GC Parameters
Carrier Gas: Helium
Column Flow: 1.0mL/min
Injection Mode: Splitless
Inlet Temperature: 250˚C
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Figure 14. GC/MS-SIM 100ppm Standard Mix 
 
 
Figure 15. GC/MS-SIM QuEChERS Extraction from Spiked Synthetic Urine 
 
 
Table 3. Summary of Retention Times for QuEChERS Study 
 
 
 
 
Drug of Abuse Retention Time Ion of Interest
AMP 5.58 56
METH 5.97 58
SECO 9.94 168
PCP 10.56 200
MTD 11.73 72
NOR 12.14 202
20 
 
Table 3 summarizes the retention times at which each analyte was identified. Figure 14 
shows the results for an un-extracted mixture of all 10 drugs of abuse. It is very clear that not all 
10 were successfully identified with this method. THC and BZE were not present because they 
require derivatization for analysis on GC. OXA and MOR are also not present, meaning there are 
interactions or interferences occurring between these analytes, rendering OXA and MOR 
undetectable.  Figure 15 shows the results for the drug mixture extracted from synthetic urine 
using the QuEChERS method. The concentration of the analytes in both figures is 100ppm, but 
the peak sensitivity and shape are not the same. AMP, METH and PCP decreased in sensitivity, 
and SECO dropped out. It is clear from this study that extracting and detecting several drugs of 
abuse with a single method is challenging. The following studies will further discuss these 
difficulties.  
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MS Parameters
EI Source: 230˚C
Transfer Line: 280˚C
Oven Parameters 
60˚C (hold for 1 min)
20˚C/min to 300˚C (hold 3 min)
GC Parameters
Carrier Gas: Helium
Column Flow: 1.0mL/min
Injection Mode: Splitless
Inlet Temperature: 250˚C
Chapter 3 – Identification of Drugs in a Mixture  
 Standard references were obtained from Sigma Aldrich for all 10 drugs of interest. The 
standards are Cerilliant certified reference materials suitable for drug testing and forensic 
analysis. Each vial contained 1mL of 1.0mg/mL in methanol (MeOH), except THC, which was 
0.1mg/mL in MeOH. Standard stock solutions were prepared by adding 1mL of each standard to 
10mL volumetric flask and diluting with MeOH. THC was not diluted. Final concentration of the 
stock solutions was 0.1mg/mL, or 100ppm. The standard solutions were analyzed individually 
for composition identification and retention time. A mixture of 8 drugs at 100ppm each (the 
initial mixture of drug standards excludes THC and BZE due to the need for derivatized) was 
prepared by adding 150μL from each stock solution to a test tube, in sequence. As each analyte 
was added, the MeOH was evaporated to dryness. The dry residue was reconstituted with 150μL 
of MeOH. All samples were injected in the Shimadzu GC/MS under the following conditions:          
Table 4. Instrumental GC Parameters    Table 5. Instrumental MS and Oven Parameters  
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16. Figure 16. 100ppm Standards Overlay (AMP, METH, SECO, PCP, MTD, NOR, OXA, MOR) 
 
 
 
17. Figure 17. Mass Spectrum for AMP (3.627 min) 
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18. Figure 18. Mass Spectrum for METH (4.050 min) 
 
 
19. Figure 19. Mass Spectrum for SECO (8.020 min) 
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20. Figure 20. Mass Spectrum for PCP (8.530 min) 
 
 
 
21. Figure 21. Mass Spectrum for MTD (9.780 min) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
50 100 150 200 250 300 350 400
0
25
50
75
100
%
200
242
91
186
166
117
104 14341 56
215 281 341327 355267 387309
50 100 150 200 250 300 350 400
0
25
50
75
100
%
72
91 165115 17844 223 294152 207 236 265 310 327 356 377
399
R
el
at
iv
e 
 
In
te
n
si
ty
 
m/z 
R
el
at
iv
e 
 
In
te
n
si
ty
 
m/z 
25 
 
22. Figure 22. Mass Spectrum for NOR (10.097 min) 
 
 
 
23. Figure 23. Mass Spectrum for OXA (10.660 min) 
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24. Figure 24. Mass Spectrum for MOR (11.090 min) 
 
 
 
25. Figure 25. Mass Spectrum for BZE (10.363 min) 
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26. Figure 26. Mass Spectrum for THC (12.180 min) 
 
 
 
27. Figure 27. 100ppm Mixture (AMP, METH, SECO, PCP, MTD, NOR, OXA, MOR) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
50 100 150 200 250 300 350 400 450
0
25
50
75
100
%
371
73
473
297 355
398
289
209 41745 14795 327247119 215165 490445
A
b
u
n
d
an
ce
 
Retention Time (min) 
R
el
at
iv
e 
 
In
te
n
si
ty
 
m/z 
28 
 
28. Figure 28. 100ppm Standard/ Mixture (AMP+METH) 
 
 
 
 
29. Figure 29. 100ppm Standard/ Mixture (SECO+PCP) 
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30. Figure 30. 100ppm Standard/ Mixture (MTD+NOR) 
 
 
 
 
31. Figure 31. 100ppm Standard/ Mixture (OXA+MOR) 
 
 
 
 
Table 6. Analyte Retention Time and Ions of Interest 
 
 
 
 
 
 
 
 
Drugs of Interest RT (min) Ions of Interest
Amphetamine 3.627 44, 65, 91
Methamphetamine 4.050 58, 91, 115
Secobarbital 8.020 167, 124, 195
Phencyclidine 8.530 200, 117, 166
Methadone 9.780 72, 91, 165
Nortriptyline 10.097 44, 189, 202
Oxazepam 10.660 77, 205, 233
Morphine 11.090 285, 162, 215
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Figure 16 is a compilation of all 8 drug standard chromatograms, overlaid to visualize 
relative retention times and peak shapes. Figures 17 – 26 represent the mass spectra for all 8 
analyzable drugs (Figure 17 show AMP, Figure 18 show METH, then SECO, PCP, MTD, NOR, 
OXA, MOR, BZE, and lastly Figure 26 shows THC). Figure 27 is the chromatogram for the 
mixture of the same 8 drugs in Figure 16, at 100ppm. Since the individual standards and the 
mixture were at the same concentration, the peaks for each drug in both figures should look 
identical. However, it is very clear that they are not. Of the 8 drugs in the initial mixture, 7 were 
successfully identified by the instrument. OXA is the only compound unable to be detected in the 
mixture. It is also important to note that the sensitivity of AMP, NOR, and MOR are also 
significantly hindered in a mixture.  Figures 28 – 31 show the chromatograms for each standard 
drug solution on top the chromatogram of the original mixture in Figure 27. This compares the 
retention time and abundance of the drugs standards to the mixture.  
In Figure 28, it can be reasoned that AMP has two peaks that are characteristic to it. 
However, the library database identifies only the left peak as AMP. It is apparent that significant 
interference occurs with AMP in this mixture. It is also clear from Figure 28 that there is very 
little effect on METH (blue peak) in the same mixture. Figures 29 and 30 demonstrate that the 
presence of additional analytes had a very small effect on SECO, PCP and MTD. It also appears 
in Figure 30 that NOR is significantly affected by the mixture. As stated previously OXA was 
not identified at all in the mixture. Figure 31 displays where OXA should be seen (in pink) with 
no corresponding peak in the mixture (black). Figure 31 also shows that MOR suffers a 
significant decrease in sensitivity from the other compounds. 
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Chapter 4 – Standards Stability Comparison 
 
This comparison study tested the stability of each drug standard in MeOH over time by 
collecting data on two separate days. All standard drug solutions were prepared at 100ppm and 
initially analyzed on 2/18/16. The same standard solutions were re-analyzed on 3/29/16 with the 
same method and instrumental parameters (listed in chapter 3). 
 
 
32. Figure 32. Amphetamine Standard Comparison (3/29/16, 2/18/16) 
 
 
 
 
33. Figure 33. Methamphetamine Standard Comparison (3/29/16, 2/18/16) 
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34. Figure 34. Secobarbital Standard Comparison (3/29/16, 2/18/16) 
 
 
 
 
 
35. Figure 35. Phencyclidine Standard Comparison (3/29/16, 2/18/16) 
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36. Figure 36. Methadone Standard Comparison (3/29/16, 2/18/16) 
 
 
 
 
37. Figure 37. Nortriptyline Standard Comparison (3/29/16, 2/18/16) 
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38. Figure 38. Oxazepam Standard Comparison (3/29/16, 2/18/16) 
 
 
 
 
39. Figure 39. Morphine Standard Comparison (3/29/16, 2/18/16) 
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Figures 32 – 39 show an over lay of the two chromatograms from each day for AMP, 
METH, SECO, PCP, MTD, NOR, OXA, and MOR (2/18/16 in pink and 3/29/16 in black). 
Figure 30 makes it very clear that the AMP standard has two characteristic peaks. The instrument 
library identified the first peak at 3.63 minutes as AMP. The second peak had no library matches, 
but may be forming as a result of oxidative dehydration of methanol [10]. The unusual 
phenomenon found is that the sensitivity of AMP increased over time. The same occurrence was 
seen with METH in Figure 33.  A possible explanation for this is that over time, some of the 
MeOH the standards were prepared in had evaporated, inadvertently increasing the overall 
concentration of the stock solution. SECO (Figure 34) displayed a small decrease in sensitivity 
over time. However, as seen in Figures 35, 36, and 37, PCP, MTD, and NOR respectively all 
show insignificant differences in sensitivity which has no effect on the overall nature of this 
study. Interestingly, Figures 38 and 39 clearly demonstrate that OXA and MOR are not stable in 
MeOH over time because the sensitivity of both analytes decreased so significantly that proper 
identification was not achieved. This conclusion may explain some complications encountered in 
later studies.  
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Chapter 5 – Interference Study 
 One of the most informative experiments performed was the interference study. The goal 
of this was to identify exactly which analytes interact with each other, causing the decreases in 
sensitivity seen in the original mixture. The interferences were tested in two ways. The first was 
7 different mixtures, and in each mixture one analyte was added according to the following: 
Mix 1: AMP, METH  
Mix 2: AMP, METH, SECO  
Mix 3: AMP, METH, SECO, PCP  
Mix 4: AMP, METH, SECO, PCP, MTD   
Mix 5: AMP, METH, SECO, PCP, MTD, NOR 
Mix 6: AMP, METH, SECO, PCP, MTD, NOR, OXA 
Mix 7: AMP, METH, SECO, PCP, MTD, NOR, OXA, MOR  
 
 The order was determined by retention time and the mixtures were prepared at 100ppm. The 
second study was done by preparing mixtures of two analytes at 50ppm, with the result being 28 
mixtures as follows: 
Table 7. Summary of Interference Study Mixtures  
 
The instrumental and method parameters were the same as the previous studies.  
SECO + NOR MTD + NOR
SECO + MTD MTD + PCP
SECO + PCP MTD + AMP
SECO + AMP MTD + METH
SECO + METH MTD + OZA
SECO + OXA MTD + MOR
SECO + MOR
METH + OXA
PCP + AMP METH + MOR
PCP + METH OXA + MOR
PCP + OXA
PCP + MOR NOR + PCP
NOR + AMP
AMP + METH NOR + METH
AMP + OXA NOR + OXA
AMP + MOR NOR + MOR
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40. Figure 40. Interference Mix 1 – 4 (Mix 1, Mix 2, Mix 3, Mix 4) 
 
 
 
 
41. Figure 41. Interference Mix Focus on AMP (Mix 1, Mix 2, Mix 3, Mix 4) 
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42. Figure 42. AMP Standard vs AMP/MTD Mix 
 
 
 
 
43. Figure 43. AMP Standard vs AMP/SECO Mix 
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44. Figure 44. AMP Standard vs AMP/METH Mix 
 
 
 
 
45. Figure 45. AMP Standard vs AMP/PCP Mix 
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46. Figure 46. AMP Standard vs AMP/OXA Mix 
 
 
 
 
47. Figure 47. AMP Standard vs AMP/MOR Mix 
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48. Figure 48. AMP Standard vs AMP/NOR Mix 
 
 
 
 
Figure 40 represents mixtures 1 – 4 and Figure 41 is zoomed in on the AMP peak from 
mixtures 1 – 4. The most significant interferences were seen with AMP in these 4 mixtures, so 
the focus of this chapter is on the AMP interferents. The AMP peak experienced a decrease in 
sensitivity each time an analyte is added to the mixture. This is one reason why AMP saw a huge 
decrease in sensitivity in the original mixture. Additionally, in mixture 4, the AMP is affected so 
considerably that the instrument is no longer able to identify the peak as AMP. The analyte 
added in mixture 4 was MTD, meaning the MTD was the main analyte that makes AMP 
unidentifiable in the original mixture.  
 Figure 42 – 48 shows the results for the second interference study for AMP. Standard 
AMP at 50ppm was compared to each AMP mixture. Figure 42 demonstrates the drastic 
decrease in sensitivity of AMP caused by MTD. By comparing the AMP to SECO, METH and 
PCP (Figures 43, 44 and 45 respectively) it was determined that these three analytes had no 
negative effects on the detection or identification of AMP. Figure 46, 47 and 48 indicate that 
OXA, MOR and NOR all caused significant decreases in the sensitivity of the AMP peak, 
contributing to difficulty in AMP detection and identification.  
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Table 8. Results of Individual Interference Study 
 
 
 
Table 8 shows the results for all 28 mixtures in the interference study. The table is read 
from left to right. For example: the sensitivity of METH is affected by AMP, PCP and OXA. The 
most important results from this table shows that the sensitivity of both OXA and MOR was 
heavily affected by the presence of every single other analyte used in this study. These results 
explain why MOR almost and OXA completely disappears from the original mixture.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AMP METH SECO PCP MTD NOR OXA MOR
AMP X X X X
METH X X X
SECO
PCP X
MTD
NOR X X X
OXA X X X X X X X
MOR X X X X X X X
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Chapter 6 – AMP/MTD Interference Study  
 
Some of the more significant results from the interference study in chapter 4 show that MTD 
substantially interacted with AMP in a mixture, making AMP unidentifiable. To further 
investigate this interaction, a 100ppm mixture of AMP and MTD was run under the same 
conditions as the interference studies.  
 
49. Figure 49. 100ppm AMP+MTD Mixture, AMP Standard and MTD standard  
 
 
 
 
50. Figure 50. Focus on AMP: AMP+MTD Mixture, AMP Standard 
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51. Figure 51. Focus on MTD: AMP+MTD Mixture, MTD standard 
 
  
 
A comparison of the AMP peaks in Figure 50 indicate that MTD significantly reduces the 
sensitivity of AMP in a mixture. Figure 51 also shows a small decrease in the sensitivity of MTD 
in the same mixture. Literature research of this interaction provided a possible explanation for 
this reaction. These two drugs may be reacting with each other by an addition elimination 
reaction as follows: 
  R2C=O + R’NH2 ⇋  R’NH–(R2)C–O–H ⇋ R2C=NR’ + H2O 
MTD, a ketone, and AMP, a primary amine, react to form a Schiff Base. This base, identified 
as N-Methyliminopropylbenzene, is the small peak in Figure 50 where AMP should be in the 
mixture (around 3.65 min). Therefore AMP and MTD react to form an imine derivative, making 
identification and detection of AMP challenging.  
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Chapter 7 – Multiple Reaction Monitoring (MRM) Scan 
 
 The next stage in developing the method for the detection of multiple drugs of abuse is 
using MRM scans. Multiple Reaction Monitoring has the capability to amplify sensitivity and 
detect trace levels of analytes. This method was completed through a series of steps. The first 
step was to obtain a chromatogram of the mixture as a regular full scan (GC/MS, Figure 27). 
From this original chromatogram the precursor, or parent, ion was selected from the mass 
spectrum for each analyte. This peak is usually the base peak, with a mass high enough to be 
fragmented further. The next step was to optimize the collision energies that best fragment the 
precursor ions into their product, or daughter, ions. The mixture was analyzed 5 times with 
collision energies ranging from 10eV to 30eV. The optimum collision energy for each ion 
transition (precursor ion fragmented to product ion) was input as part of the method parameters. 
The instrumental parameters remained the same as the previous studies. 
 
 
52. Figure 52.Chromatogram of PCP for Product Ion Selection (10eV, 15eV, 20eV, 25eV, 30eV) 
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53. Figure 53. Mass Spectrum for PCP at 10eV 
 
 
 
54. Figure 54. Mass Spectrum for PCP at 15eV 
 
 
 
55. Figure 55. Mass Spectrum for PCP at 20eV 
 
 
 
56. Figure 56. Mass Spectrum for PCP at 25eV 
 
 
 
57. Figure 57. Mass Spectrum for PCP at 30eV 
 
 
 
 
 
 
 
 
 
 
 
40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220
0
500000
2
0
0
1
1
7
8
4
1
7
1
9
1
1
4
4
5
6
1
3
2
1
8
5
1
5
7
9
8
1
0
5
7
0
4
2
2
1
3
40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220
0
500000
1
1
7
8
4
2
0
0
9
1
1
7
1
5
6
1
4
3
9
8
1
3
2
1
8
4
1
5
7
6
7
4
2
1
0
5
2
0
5
2
1
5
40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220
0
500000
9
1
1
3
2
1
7
2
2
1
5
1
1
7
8
4
1
4
4
5
6
4
1
1
5
6
1
0
3
1
8
5
6
7
5
1
1
9
5
40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220
0
250000
500000 1
1
5
9
1
8
4
5
6
1
7
0
1
4
3
1
1
4
4
2
6
7
2
0
0
1
5
6
9
8
1
2
8
1
8
4
1
5
3
40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220
0
250000
500000
1
1
5
9
1
8
4
5
6
1
4
3
1
7
0
1
1
4
4
1
6
5
2
0
0
1
5
6
1
3
0
1
0
2
1
8
4
1
5
3
A
b
u
n
d
an
ce
 
m/z 
In
te
n
si
ty
 
m/z 
In
te
n
si
ty
 
m/z 
In
te
n
si
ty
 
m/z 
In
te
n
si
ty
 
m/z 
47 
 
 The results of the optimization for PCP are shown to demonstrate the process of MRM 
method development. To determine the product ions and optimum collision energies, the 
chromatograms for all 5 runs were loaded into data comparison software. Figure 52 includes all 5 
data sets, and by clicking the chromatogram at the corresponding retention time for the particular 
drug (8.530 min for PCP), the mass spectrum at each collision energy is shown. Figures 53 – 57 
respectively represent the individual collision energies and corresponding fragmentation patterns 
for 10eV, 15eV, 20eV, 25eV and 30eV. Three product ions were chosen in addition to the base 
peak (167): 117, 115 and 84. An optimum collision energy was also chosen for each ion 
transition (167>117, 167>115, 167>84). This was done by comparing the abundance of the 
peaks for every ion chosen. For PCP, the best collision energies for 117, 115, and 84 were 15eV, 
25eV, and 15eV respectively. The selected product ions and optimized collision energies were 
saved as part of the method parameters. The last step is running the MRM scan.   
 
Table 9. Summary of Precursor/Product Ions and Transition Collision Energies 
 
 
 
 
 
 
AMP METH SECO PCP MTD NOR MOR
Precursor Ion 91 91 167 200 72 202 162
Product Ion 1 65 65 124 117 70 200 147
Product Ion 2 63 63 106 115 57 176 134
Product Ion 3 41 41 96 84 44 152 42
Transition 1 CE 15 15 10 15 15 25 15
Transition 2 CE 20 25 15 25 15 25 10
Transition 3 CE 15 15 10 15 15 25 15
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58. Figure 58. MRM Event 1 at 100ppm 
 
 
 
 
59.  Figure 59. MRM Event 2 at 100ppm  
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60. Figure 60. MRM Event 1 at 10ppm 
 
 
 
 
61. Figure 61. MRM Event 2 at 10ppm  
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 Figures 58 – 61 show the MRM scans for a 100ppm and a 10ppm mixture. For each 
concentration there are two figures, titled Event 1 and Event 2. Part of the MRM method 
development was choosing a fragmentation pattern and corresponding collision energies. The 
instrument will only scan for these selected ion fragments at certain retention times, following 
the chosen parameters. The dwell time for this scan is 0.3 seconds. If the instrument does not 
recognize the fragmentation pattern in the first scan, it will rescan for another 0.3 seconds to find 
the ions. These two scans represent Event 1 and Event 2. Figure 58 is Event 1 at 100ppm, and 
detected AMP, METH, SECO, MTD and MOR. Figure 59 shows Event 2 at 100ppm, which 
identified AMP, METH, PCP and NOR. A possible explanation for why AMP and METH 
appeared in both Events is that they both have the same characteristic fragmentation patterns 
with similar retention times. After successfully detecting 7 drugs, the same MRM method was 
performed on a mixture at 10ppm. Figure 60 shows Event 1 and Figure 61 shows Event 2 at 
10ppm. At the diluted concentration, METH and MOR were lost, but AMP, SECO, PCP, MTD 
and NOR were successfully identified. Future work for this study should include optimization of 
the MRM parameters, which may recover the lost METH and MOR and the lower 
concentrations.  
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Chapter 8 – Derivatization Study  
 
 A major obstacle for the identification of BZE and THC using GC is that they are not 
volatile enough. In order to make them detectable, they must be derivatized. This study focuses 
on silylation reactions using BSTFA+1% TMCS. Silylation adds a trimethylsilyl group to active 
hydrogens on a molecule, so the reagent will interact with the hydroxyl groups on both THC and 
BZE [11]. As derivatization requires time, and occasionally heat, an optimization study was 
performed. 150μL of BZE was aliquoted into 16 test tubes. The solvent was evaporated to 
dryness and 150μL of derivatizing agent was added to each test tube. One set of 4 tubes was left 
at room temperature (about 25˚C) and allowed to react for increments of 10, 20, 30 and 40 
minutes. The same time study was performed with tubes using a heating block at 40˚C, 60˚C and 
80˚C. Once derivatization was complete, the BSTFA containing the analytes was directly 
injected onto the GC column following the same instrumental parameters are the previous 
studies.  
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62. Figure 62. Derivatization Optimization of BZE at 25˚C (10min, 20min, 30min, 40min) 
 
 
 
 
63. Figure 63. Derivatization Optimization of BZE at 40˚C (10min, 20min, 30min, 40min) 
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64. Figure 64. Derivatization Optimization of BZE at 60˚C (10min, 20min, 30min, 40min) 
 
 
 
 
65. Figure 65. Derivatization Optimization of BZE at 80˚C (10min, 20min, 30min, 40min) 
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66.  Figure 66. Optimum Time Per Temperature for BZE Derivatization  
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67. Figure 67. BZE 100ppm Standard Derivatized at 25˚C for 40 minutes 
 
 
68. Figure 68. THC 100ppm Standard Derivatized at 25˚C for 40 minutes  
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To optimize the derivatization method, the four time lengths were compared according to 
temperature. Figure 62 shows the results for each time at room temperature. Figure 63 represents 
the results for 40˚C, the results in Figure 64 are at 60˚C and Figure 65 was at 80˚C. Figure 66 
compares the optimum time length for each temperature. Optimum time was determined by 
selecting the corresponding peak which had the best shape and sensitivity. It is clear from Figure 
64 that the best method was 25˚C for 40 minutes. Once the optimum parameters were 
determined, they were successfully implemented on BZE and THC (Figures 67 and 68).The 
instrument was able to identify the peaks in Figures 67 and 68 as the TMS (trimethylsilyl) 
derivatives of BZE and THC. The next challenge will be to determine how derivatization will 
affect the other drugs of abuse, and if it is possible to derivatize the mixture and still accurately 
identify the same analytes.  
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